A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
To compare the efficacy of combination oral thalidomide plus oral dexamethasone treatment to that of oral dexamethasone-alone treatments as induction (first-line) therapy for subjects with active multiple myeloma
Inclusion Criteria:
Exclusion Criteria:
Parkville, Victoria 3050, Australia
Alexandrovska, Bulgaria
Tel Litwinsky, 52621, Israel
Bari, 11, Italy
Lublin, 20-022, Poland
Warsaw, 02-097, Poland
Saint Petersburg, 193024, Russia
Saint Petersburg, 197022, Russia
Saint Petersburg, 197110, Russia
Samara, 443095, Russia
Shosse, 115478, Russia
Ivano-Frankivsk, 76000, Ukraine
Kharkiv, 61070, Ukraine
Kiev, 04060, Ukraine